Abstract
Vγ9Vδ2 Tcells are non-canonical Tcells that use their Tcell receptor to detect phosphoantigens bound to the internal domain of the HMBPP receptor (butyrophilin 3/2A1 complex). This protocol describes the expansion and purification of human effector Vγ9Vδ2 Tcells from human buffy coat and describes how to assess their activation by antigen-containing target cells. While specifically focused on cytokine production, this protocol can be readily adapted to evaluate other effector functions of activated Vγ9Vδ2 Tcells. For complete details on the use and execution of this protocol, please refer to Hsiao etal. (2022) and Hsiao and Wiemer (2018).
Full Text
Topics from this Paper
Vγ9Vδ2 Tcells
Human Buffy Coat
Human Vγ9Vδ2 Tcells
Antigen-containing Cells
Generation Of Tcells
+ Show 5 more
Create a personalized feed of these topics
Get StartedTalk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
Immunity
Apr 1, 2019
Blood
Dec 3, 2015
The Journal of Infectious Diseases
Mar 28, 2012
International Journal of Infectious Diseases
Jun 1, 2012
The Journal of Immunology
May 1, 2019
Journal for ImmunoTherapy of Cancer
Nov 1, 2022
Clinical Immunology
Feb 1, 2012
The Journal of Infectious Diseases
Mar 27, 2017
Cellular and Molecular Life Sciences
Feb 20, 2011
European Journal of Immunology
May 25, 2011
STAR protocols
Jun 1, 2022
Frontiers in Immunology
Jan 13, 2023
Blood
Nov 22, 2018
Frontiers in Immunology
Apr 19, 2018
Clinical Cancer Research
Nov 14, 2012
STAR protocols
STAR protocols
Dec 1, 2023
STAR protocols
Dec 1, 2023
STAR protocols
Dec 1, 2023
STAR protocols
Dec 1, 2023
STAR protocols
Dec 1, 2023
STAR protocols
Dec 1, 2023
STAR protocols
Dec 1, 2023
STAR protocols
Dec 1, 2023
STAR protocols
Dec 1, 2023
STAR protocols
Dec 1, 2023